We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MIT Accuses Shire’s Dermagraft of Infringing Skin Growth Patents
MIT Accuses Shire’s Dermagraft of Infringing Skin Growth Patents
January 11, 2013
Shire Pharmaceuticals and its Shire Regenerative Medicine (SRM) subsidiary are facing civil charges of violating patents held by the Massachusetts Institute of Technology and Children’s Medical Center Corporation (CCMC) in marketing a diabetic foot ulcer treatment.